S06-1011
hBChE IC50 = 16 nM
General
Type : Quinoline,Imidazole,Oxadiazol,Benzimidazole
Chemical_Nomenclature : 2-[2-(4-amino-1,2,5-oxadiazol-3-yl)benzimidazol-1-yl]-N-quinolin-3-ylacetamide
Canonical SMILES : C1=CC=C2C(=C1)C=C(C=N2)NC(=O)CN3C4=CC=CC=C4N=C3C5=NON=C5N
InChI : InChI=1S\/C20H15N7O2\/c21-19-18(25-29-26-19)20-24-15-7-3-4-8-16(15)27(20)11-17(28)23-13-9-12-5-1-2-6-14(12)22-10-13\/h1-10H,11H2,(H2,21,26)(H,23,28)
InChIKey : FPAMWJFOROLHQH-UHFFFAOYSA-N
Other name(s) : CHEMBL5093535,BDBM50582481
MW : 385.4
Formula : C20H15N7O2
CAS_number :
PubChem : 141740365
UniChem : FPAMWJFOROLHQH-UHFFFAOYSA-N
IUPHAR :
Wikipedia :
Target
References (1)
| Title : Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection - Li_2021_J.Med.Chem__ |
| Author(s) : Li Q , Chen Y , Xing S , Liao Q , Xiong B , Wang Y , Lu W , He S , Feng F , Liu W , Sun H |
| Ref : Journal of Medicinal Chemistry , : , 2021 |
| Abstract : Li_2021_J.Med.Chem__ |
| ESTHER : Li_2021_J.Med.Chem__ |
| PubMedSearch : Li_2021_J.Med.Chem__ |
| PubMedID: 33973470 |